phrykt

West Pharmaceutical Services (WST) net income: $494M

West Pharmaceutical Services reported a net income of $494M for the year ended Dec 31, 2025, up 0.2% from $493M a year earlier.

From West Pharmaceutical Services's filings with the SEC · Read the filing · WST stock page

West Pharmaceutical Services net income by year

$662M2021$586M2022$593M2023$493M2024$494M2025

#592 of 3,748 US companies by net income · See the full ranking

Year endedNet incomeChange
Dec 31, 2025$494M+0%
Dec 31, 2024$493M-17%
Dec 31, 2023$593M+1%
Dec 31, 2022$586M-11%
Dec 31, 2021$662M–

Net income of similar companies

Companies in the same industry as West Pharmaceutical Services, by SEC industry code, with the closest net income. Each name opens the same page for that company.

CompanyNet income, latest yearYear ended
Solventum$1.6BDec 31, 2025
Resmed$1.5BJun 30, 2026
Dexcom$836MDec 31, 2025
Globus Medical$538MDec 31, 2025
West Pharmaceutical Services$494MDec 31, 2025
Insulet$247MDec 31, 2025
Penumbra$178MDec 31, 2025

Questions and answers

What is West Pharmaceutical Services's net income?

West Pharmaceutical Services reported a net income of $494M for the year ended Dec 31, 2025, up 0.2% from $493M a year earlier.

Numbers as reported in West Pharmaceutical Services's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology